Theremia
Paris, France
Theremia aims to revolutionize drug development by using advanced machine learning and causal algorithms to improve drug efficacy and minimize side effects for diverse patient populations. Their interdisciplinary team focuses on enhancing clinical trials, shortening development times, and optimizing treatment outcomes in precision medicine and pharmacology.
Company Info
- Founded
- 2023
- Website
- www.theremia.health/
Only accessible to MedStartr community members.
Join nowWhat do you think of Theremia?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.